Variation in the Estimation of Quality‐adjusted Life‐years by Different Preference‐based Instruments

Objectives. To assess the interchangeability of preference‐based health‐related quality of life tools and compare the potential gains in quality‐adjusted life years (QALYs) in patients with musculoskeletal disease. Methods. Consecutive patients visiting a rheumatology clinic completed health‐related quality of life assessments at baseline and 3, 6, and 12 months with the EuroQol (EQ‐5D), Health Utilities Index (HUI3), and Short‐Form 6D (SF‐6D). Patients rated their health changes retrospectively and responses were categorized into three groups: better, same, and worse. Correlations and repeated measures analysis of variance with post hoc contrasts and a Bonferroni correction were used to assess interchangeability of tools. Results. Results were based on 161 cases with complete baseline data and 98 cases with data at baseline and 12 months. Correlations ranged from 0.66 to 0.79. An interaction effect showed that for the better group, the EQ‐5D showed a significantly greater mean improvement (0.15) than the HUI3 (0.07) or the SF‐6D (0.05). For the worse group, the EQ‐5D showed a significantly greater mean decrease (0.19) than either the HUI3 (0.05) or the SF‐6D (0.03). QALYs differences between the better and worse groups were significantly greater (0.23) with the EQ‐5D than with the HUI3 (0.11) or the SF‐6D (0.09). Conclusions. Although results moderately support the idea that the three tools are measuring a similar underlying construct, the tools are not interchangeable because they are scaled differently and produce varying results. These findings have potential implications for the interpretation and comparability of health outcome studies and economic analyses. Possible approaches are sensitivity analysis or standardization of scores before calculation of QALYs.

[1]  J. Bosch,et al.  Comparison of the Health Utilities Index Mark 3 (HUI3) and the EuroQol EQ-5D in patients treated for intermittent claudication , 2004, Quality of Life Research.

[2]  E. Rowland Theory of Games and Economic Behavior , 1946, Nature.

[3]  P. Dolan,et al.  Valuing health states: a comparison of methods. , 1996, Journal of health economics.

[4]  M. Essink‐bot,et al.  The EQ-5D and the Health Utilities Index for permanent sequelae after meningitis: a head-to-head comparison. , 2002, Journal of clinical epidemiology.

[5]  J. Nabholtz,et al.  Responsiveness of the EuroQol in breast cancer patients undergoing high dose chemotherapy , 2004, Quality of Life Research.

[6]  G. Regehr,et al.  Methodological problems in the retrospective computation of responsiveness to change: the lesson of Cronbach. , 1997, Journal of clinical epidemiology.

[7]  Robert L. Mason,et al.  Statistical Principles in Experimental Design , 2003 .

[8]  P. Kind,et al.  Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D). , 1997, British journal of rheumatology.

[9]  R. Jarrett,et al.  Economics of coronary artery bypass grafting , 1985, British medical journal.

[10]  M. Weinstein,et al.  Recommendations of the Panel on Cost-effectiveness in Health and Medicine. , 1996, JAMA.

[11]  G. Samsa How should the minimum important difference for a health-related quality-of-life instrument be estimated? , 2001, Medical care.

[12]  Samuel T. Mayo,et al.  Statistical methods in education and psychology , 1979 .

[13]  R. Brooks EuroQol: the current state of play. , 1996, Health policy.

[14]  S. Wilson Methods for the economic evaluation of health care programmes , 1987 .

[15]  Jacob Cohen Statistical Power Analysis for the Behavioral Sciences , 1969, The SAGE Encyclopedia of Research Design.

[16]  P. Dolan,et al.  Time preference, duration and health state valuations. , 1995, Health economics.

[17]  C. Bell,et al.  A Comprehensive League Table of Cost-Utility Ratios and a Sub-table of "Panel-worthy" Studies , 2000, Medical decision making : an international journal of the Society for Medical Decision Making.

[18]  M. Sprangers,et al.  Innovations and dilemmas in psychosocial oncology. Contributions from the 10th conference of the European Society for Psychosocial Oncology. , 1999, Acta oncologica.

[19]  W. Kuipers,et al.  Intermittent claudication: symptom severity versus health values. , 1998, Journal of vascular surgery.

[20]  G. Hawthorne,et al.  A comparison of the Assessment of Quality of Life (AQoL) with four other generic utility instruments , 2001, Annals of medicine.

[21]  J. Brazier,et al.  A comparison of the EQ-5D and SF-6D across seven patient groups. , 2004, Health economics.

[22]  F. Wolfe,et al.  Measurement of the quality of life in rheumatic disorders using the EuroQol. , 1997, British journal of rheumatology.

[23]  W. Maksymowych,et al.  The responsiveness of generic health status measures as assessed in patients with rheumatoid arthritis receiving infliximab. , 2003, The Journal of rheumatology.

[24]  E. Halpern,et al.  Comparison of Preference-Based Utilities of the Short-Form 36 Health Survey and Health Utilities Index before and after Treatment of Patients with Intermittent Claudication , 2002, Medical decision making : an international journal of the Society for Medical Decision Making.

[25]  G. Guyatt,et al.  Relation of Distribution- and Anchor-Based Approaches in Interpretation of Changes in Health-Related Quality of Life , 2001, Medical care.

[26]  D. Gladman,et al.  Methods for assessing responsiveness: a critical review and recommendations. , 2000, Journal of clinical epidemiology.

[27]  J. Pater Quality of life and pharmacoeconomics in clinical trials , 1996 .

[28]  B. Spilker,et al.  Quality of life and pharmacoeconomics in clinical trials , 1996 .

[29]  M. Sprangers,et al.  Revealing response shift in longitudinal research on fatigue--the use of the thentest approach. , 1999, Acta oncologica.

[30]  J. Brazier,et al.  The estimation of a preference-based measure of health from the SF-36. , 2002, Journal of health economics.

[31]  K C Cain,et al.  Measuring Preferences for Health States Worse than Death , 1994, Medical decision making : an international journal of the Society for Medical Decision Making.

[32]  M. Weinstein,et al.  Evaluating the cost-effectiveness of clinical and public health measures. , 1998, Annual review of public health.

[33]  John Brazier,et al.  A review of the use of health status measures in economic evaluation. , 1999, Health technology assessment.

[34]  H. Gulliksen Theory of mental tests , 1952 .

[35]  G. Guyatt,et al.  Assessing the minimal important difference in symptoms: a comparison of two techniques. , 1996, Journal of clinical epidemiology.

[36]  H. Woo,et al.  A comparison of techniques for eliciting patient preferences in patients with benign prostatic hyperplasia. , 2002, The Journal of urology.

[37]  M. Suarez‐Almazor,et al.  Rating of arthritis health states by patients, physicians, and the general public. Implications for cost-utility analyses. , 2001, The Journal of rheumatology.

[38]  P. Dolan,et al.  Modeling valuations for EuroQol health states. , 1997, Medical care.

[39]  M. Snaith,et al.  Generic and condition-specific outcome measures for people with osteoarthritis of the knee. , 1999, Rheumatology.

[40]  A. Detsky,et al.  Canadian guidelines for economic evaluation of pharmaceuticals. Canadian Collaborative Workshop for Pharmacoeconomics. , 1996, PharmacoEconomics.

[41]  C. Terwee,et al.  A taxonomy for responsiveness? , 2002, Journal of clinical epidemiology.

[42]  A. Tversky,et al.  The framing of decisions and the psychology of choice. , 1981, Science.

[43]  P. Kind,et al.  “Death” and the Valuation of Health-Related Quality of Life , 2001, Medical care.

[44]  H. Glick,et al.  Preference-based quality-of-life in patients with Parkinson’s disease , 2002, Neurology.

[45]  R. Linn Educational measurement, 3rd ed. , 1989 .

[46]  L. Cronbach,et al.  How we should measure "change": Or should we? , 1970 .